Table 3.
Clinical Characteristics of Adult DM Patients Attending a General Hospital in Eastern Ethiopia, 2020 (N= 325)
| Variables | Category | Frequency (n) | Percent (%) |
|---|---|---|---|
| Type of DM | Type I | 155 | 47.7 |
| Type II | 170 | 52.3 | |
| Duration of DM | ≤1 year | 91 | 28.0 |
| 1–5 years | 111 | 34.2 | |
| ≥5 years | 123 | 37.8 | |
| Presence of co-morbidity | Yes | 91 | 28.0 |
| No | 234 | 72.0 | |
| Medications used for DM | Oral hypoglycemic agents | 146 | 44.9 |
| Insulin | 172 | 52.9 | |
| Both | 7 | 2.2 | |
| Medications taken for co-morbidities | Yes | 71 | 21.8 |
| No | 254 | 78.2 | |
| DM complicationsa | Yes | 76 | 23.4 |
| No | 249 | 76.6 | |
| Blood glucose level | Controlled | 82 | 25.2 |
| Uncontrolled | 243 | 74.8 | |
| Hypertension | Yes | 72 | 22.2 |
| No | 253 | 77.8 | |
| Hypertension (n= 72) | Controlled | 40 | 55.6 |
| Uncontrolled | 32 | 44.4 | |
| Stool examination | Positive | 4 | 1.2 |
| Negative | 321 | 98.8 |
Note: aNeuropathy, nephropathy, retinopathy, diabetic foot ulcer, and cardiovascular diseases.